Showing 4061-4070 of 4164 results for "".
- First International MIGS Data for the Omni Surgical System Presented at ESCRShttps://modernod.com/news/first-international-migs-data-for-the-omni-surgical-system-presented-at-escrs/2476893/Sight Sciences announced clinical results from the first study of the Omni Surgical System in glaucoma patients were presented at the European Society of Cataract and Refractive Surgery (ESCRS). Findings from the pilot study suggest the Omni Surgical System, which is dually indicated in
- Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meetinghttps://modernod.com/news/kodiak-sciences-announces-emerging-durability-data-from-ongoing-phase-1b-study-of-ksi-301-in-wet-amd-patients-at-the-retina-society-annual-meeting/2476886/Kodiak Sciences announced emerging durability data in patients with wet age-related macular degeneration (AMD) treated in its phase 1b clinical study of its investigational therapy KSI-301. The results were presented by David M. Brown</
- PhysIOL to Launch FineVision Triumf Trifocal EDOF IOLhttps://modernod.com/news/physiol-to-launch-finevision-triumf-trifocal-edof-iol/2476879/BVI, through its PhysIOL subsidiary, announced the European launch of the FineVision Triumf EDOF trifocal presbyopia correcting IOL. Results from a year of clinical studies will be presented at the European Society for Cataract and Refractive Surgeons (ESCRS), held Septembe
- The American Academy of Ophthalmology and Verana Health Launch Verana Practice Insights to Innovate Patient Carehttps://modernod.com/news/the-american-academy-of-ophthalmology-and-verana-health-launch-verana-practice-insights-to-innovate-patient-care/2476864/The American Academy of Ophthalmology (AAO) and Verana Health announced the launch of Verana Practice Insights, a new tool that aims to enable physicians to improve patient outcomes and provide better care through critical data insights and trends procured from the largest specialty clinical data
- OD-OS to Showcase Navilas Navigated Retinal Laser Therapy at EURETINAhttps://modernod.com/news/od-os-to-showcase-navilas-navigated-retinal-laser-therapy-at-euretina/2476852/OD-OS will share clinical experiences with the Navilas 577s digital treatment platform this week at the EURETINA Congress in Paris. Navigated retinal laser therapy with the Navilas 577s allows for panretinal photocoagulation with uniform spot distribution, which is faster and less painful for pat
- Kowa Submits IND Application to the FDA to Begin Phase 2 Study of Ripasudil Hydrochloride Hydratehttps://modernod.com/news/kowas-submits-ind-application-to-the-fda-to-begin-phase-2-study-of-ripasudil-hydrochloride-hydrate/2476842/Kowa, which has been developing Ripasudil Hydrochloride Hydrate, a Rho kinase inhibitor, for the indication of corneal endothelial diseases, submitted an investigational new drug (IND) application to the FDA on August 30, 2019 in order to commence a phase 2 clinical
- OKYO Pharma Announces Potent Anti-inflammatory Effects of OK-113 in a Mouse Model of Dry Eye Diseasehttps://modernod.com/news/okyo-pharma-announces-potent-anti-inflammatory-effects-of-ok-113-in-a-mouse-model-of-dry-eye-disease/2476830/OKYO Pharma has announced potent anti-inflammatory activity of OK-113, an in-house discovered proprietary agonist of Chemerin GPCR, in an experimental model of dry eye disease (DED) in mice. These preclinical efficacy data, identifying a lead drug candidate, will facilitate initiation of clinical
- Oculus to Releases New Features for the Corvis ST at ESCRShttps://modernod.com/news/oculus-to-releases-new-features-for-the-corvis-st-at-escrs/2476829/Four new software features will be introduced in the Oculus Corvis ST at the ESCRS 2019 in Paris. These updates will further increase the number of clinical applications that can be addressed based on corneal biomechanics. They include the assessment of biomechanical stability after corneal refra
- Topcon Launches the Maestro2 with Automated OCTAhttps://modernod.com/news/topcon-launches-the-maestro2-with-automated-octa/2476826/Topcon has announced the launch of the Maestro2 Automated OCT/Fundus Camera, now with OCTA. Building on the success of its predecessor, the 3D OCT-1 Maestro, the new Maestro2 adds even more clinical utility to its multimodality platform, according to a company news release. The Maestro2 is
- TopiVert Announces Topline Results from Phase 2b/3 Study of Dry Eye Disease Drug Candidatehttps://modernod.com/news/topivert-announces-topline-results-from-theia-1-phase-2b-3-clinical-study-of-top1630-as-a-treatment-for-dry-eye-disease/2476792/TopiVert Pharma announced topline results from THEIA-1 phase 2b/3 clinical study evaluating TOP1630, a novel anti-inflammatory kinase inhibitor, as an ophthalmic solution for the treatment of dry eye disease. THEIA-1, a multicenter, randomized, double-masked, placebo-controlled phase 2b/3